Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques

J Med Primatol. 2008 Jun;37(3):109-15. doi: 10.1111/j.1600-0684.2007.00251.x.

Abstract

Background: Cryptosporidium infection leads to life-threatening diarrhea in AIDS patients. Pathogenesis of cryptosporidiosis is due to intestinal physiological alterations. We devised an ex-vivo model using ex-vivo Cryptosporidium parvum infection of jejunal tissues derived from SIV-infected macaques and studied the role of substance P (SP) in the pathogenesis of cryptosporidiosis.

Methods: We measured jejunal SP protein levels using ELISA, and electrophysiological alterations using the Ussing chamber technique in an ex vivo model of Cryptosporidium infection. Paraformaldehyde-fixed jejunum from SIV-infected macaques with and without naturally occurring cryptosporidiosis was studied for SP protein expression by immunohistochemistry and fluorescence deconvolution microscopy.

Results: Ex-vivo Cryptosporidium-infected tissues and tissues from SIV-infected macaques with naturally occurring cryptosporidiosis demonstrated elevated SP protein levels compared with tissues from SIV-infected animals without ex-vivo C. parvum infection or tissues from SIV-infected animals that have no evidence of cryptosporidiosis. In our ex-vivo model of Cryptosporidium infection, we demonstrated pathophysiological alterations that were blocked by SP-receptor antagonist treatment.

Conclusions: These studies suggest that SP-receptor antagonists could prove useful for treatment of AIDS-related cryptosporidiosis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cryptosporidiosis
  • Cryptosporidium parvum / physiology*
  • Gene Expression Regulation
  • Jejunum / physiopathology*
  • Macaca
  • Neurokinin-1 Receptor Antagonists*
  • Simian Acquired Immunodeficiency Syndrome / complications*
  • Simian Immunodeficiency Virus*
  • Substance P / genetics
  • Substance P / metabolism
  • Tissue Culture Techniques

Substances

  • Neurokinin-1 Receptor Antagonists
  • Substance P